Literature DB >> 6318915

Modulation by dopamine of population responses and cell membrane properties of hippocampal CA1 neurons in vitro.

V K Gribkoff, J H Ashe.   

Abstract

Dopamine (DA) was applied to rat hippocampal slices maintained in vitro. Extracellular and intracellular recording techniques were used to study the effect of DA on population responses, membrane potentials, and membrane responses to hyperpolarizing current pulses in CA1 pyramidal cells. Temporary exposure of hippocampal slices to DA has a dual effect. The initial action of DA is to produce a suppression of the extra-cellularly recorded population responses. In individual neurons, this initial effect is seen as a membrane hyperpolarization accompanied by a decrease in the amplitude of responses to hyperpolarizing current pulses. The frequency of occurrence of spontaneous depolarizations and spikes is reduced. The early action of DA is followed by a profound potentiation of the population responses that can last for hours. This long-lasting potentiation of the population response, induced by DA, is depressed by spiroperidol, a DA antagonist. In individual neurons, the late effect of DA is a long-lasting membrane depolarization associated with an increase in the amplitude of responses to hyperpolarizing current pulses. During this late phase, spontaneous activity is increased, as are single cell responses to stimulation of afferents. The evidence presented here indicates that DA is able to induce a long-lasting modification of the excitability of CA1 hippocampal neurons. This modulation of excitability by DA may be similar in nature to previously described DA-modulatory actions in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6318915     DOI: 10.1016/0006-8993(84)90768-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Pharmacology of long-term potentiation. A model for learning reviewed.

Authors:  M Beukers; E W Boddeke
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

2.  D1/D5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses.

Authors:  N A Otmakhova; J E Lisman
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 3.  Integrating information at single synaptic connections.

Authors:  P R Montague
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus.

Authors:  Y Y Huang; E R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling.

Authors:  Antonieta Lavin; Lourdes Nogueira; Christopher C Lapish; R Mark Wightman; Paul E M Phillips; Jeremy K Seamans
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

6.  Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.

Authors:  A M Alam; M S Starr
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

7.  A cellular analogue of operant conditioning.

Authors:  L Stein; B G Xue; J D Belluzzi
Journal:  J Exp Anal Behav       Date:  1993-07       Impact factor: 2.468

8.  Modulation by dopamine of population spikes in area CA1 hippocampal neurons elicited by paired stimulus pulses.

Authors:  V K Gribkoff; J H Ashe
Journal:  Cell Mol Neurobiol       Date:  1984-06       Impact factor: 5.046

9.  An afterhyperpolarization recorded in striatal cells 'in vitro': effect of dopamine administration.

Authors:  A Rutherford; M Garcia-Munoz; G W Arbuthnott
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region.

Authors:  N A Otmakhova; J E Lisman
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.